SCHEMBL30622975

SCHEMBL30622975

CC1c2c(-c3ccnc4[nH]ccc34)c(-c3ccc(F)cc3)nn2CCN1C(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 7/20 0.44
▸ CSNK1D P48730 4/20 0.44
▸ MAPK11 Q15759 1/20 0.44
▸ AURKB Q96GD4 4/20 0.38
▸ AURKA O14965 3/20 0.38
▸ EGFR P00533 2/20 0.37
▸ JAK1 P23458 4/20 0.37
▸ JAK2 O60674 2/20 0.36
▸ TYK2 P29597 2/20 0.36
▸ JAK3 P52333 2/20 0.36
▸ CCNT1 O60563 2/20 0.35
▸ CDK9 P50750 2/20 0.35
▸ CIT O14578 1/20 0.35
▸ RPS6KA3 P51812 1/20 0.35
▸ INCENP Q9NQS7 2/20 0.35
▸ LYN P07948 1/20 0.35
▸ IGF1R P08069 1/20 0.35
▸ MET P08581 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ GRIA1 P42261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645197 1.00 MAPK14 (0.44) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL26645277 0.92 BRAF (0.39) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL30622813 0.92 BRAF (0.39) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL30622366 0.85 MAPK14 (0.46) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL26645123 0.85 MAPK14 (0.46) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL30622798 0.82 CSNK1D (0.46) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL26645620 0.82 CSNK1D (0.46) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL30622831 0.81 MAPK14 (0.43) MAPK14CSNK1DMAPK11EGFRGRIA1
SCHEMBL30622306 0.81 MAPK14 (0.42) MAPK14CSNK1DMAPK11AURKBAURKA
SCHEMBL30622344 0.81 MAPK14 (0.42) MAPK14CSNK1DMAPK11AURKBAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback